Statistically significant mean placebo-adjusted reduction of triglycerides of 36.4% at 1 gram and 38.6% at 2 gram daily doses of CaPre® Statistically significant reduction of 5.3% in non-HDL-C using 2 grams of CaPre® daily (considered the most accurate risk marker for cardiovascular disease) No increases in LDL-C (bad cholesterol) and slight increases in HDL-C (good cholesterol) Clinically meaningful mean placebo-adjusted reduction in VLDL-C of 10.9% and 13.5% at 1 gram and 2 gram daily doses CaPre®, respectively (VLDL-C is considered a highly significant predictor of cardiovascular disease) Statistically significant dose dependent improvement in Omega-3 Index (a risk factor for coronary heart disease) CaPre® shown to be safe, well tolerated and effective
LAVAL, Quebec, Sept.
In the two awards shows honoring the homebuilding industry’s best in
design, marketing and professional achievement, The New Home Company
(NEW HOME, NYSE: NWHM) earned top honors at last weekend’s Northern
California MAME Awards and the SoCal Awards.
Strongly Positive Results, Presented at European Society for Medical Oncology (ESMO) 2014 Congress, Demonstrated Oncotype DX® Prostate Cancer Test was an Independent Predictor of Tumor Aggressiveness
Study, Including 20% African-American Men, Confirmed Similar Predictive Outcomes Regardless of Race REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients investment picks
International Group (NASDAQ: EIGI ),
a leading provider of cloud-based platform solutions to help small and
medium-sized businesses succeed online, today announced it has begun to
offer Google Apps for Work to its small business subscribers.
Seagate Technology plc (NASDAQ:STX), a world leader in storage
solutions, today took the wraps off the industry’s first dedicated
surveillance hard disk drive (HDD) featuring Seagate Rescue™
services—the Seagate ® Surveillance HDD.
- Selinexor Demonstrates Clinical Activity in Prostate Cancer and other Solid Tumors - - Data from Ongoing Phase 1 Clinical Study Presented at ESMO 2014 - - Webcast Scheduled for Monday, September 29, 2014 at 4:30pm ET -
NEWTON, Mass., Sept.
Frontier Communications Corporation (NASDAQ:FTR) a leading provider of
communications services throughout 27 states and headquartered in
Connecticut since 1946, announced today the appointment of Edward H.
Corporate Resource Services, Inc. (NASDAQ:CRRS), (the “Company” or,
“CRS”), a diversified technology, staffing, recruiting, and consulting
services firm, today announced that it had received a letter from The
NASDAQ Stock Market regarding the Company’s status under Listing Rule
NASDAQ has determined that with the September 25, 2014, filing of the
Company’s Form 10-Q for the period ending July 4, 2014, the Company is
in compliance with this Rule and meets its periodic filing requirements.
& Springer LLC , a boutique securities class action law firm
focused on representing shareholders nationwide, is investigating
potential breach of fiduciary duty claims against the Board of Directors
of Athlon Energy Inc. (NYSE: ATHL) (“Athlon” or the “Company”) relating
to the sale of the Company to Encana Corporation (“Encana”). On
September 29, 2014, the two companies announced the signing of a
definitive merger agreement pursuant to which Encana will acquire Athlon
in a merger via a tender offer.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.